April 08, 2021
Article
Study is the first to examine how the choice of blood pressure medications influences the long-term risk of heart disease, stroke, and heart failure in a patient population with a higher risk of cardiovascular disease.
April 05, 2021
The research team analyzed CD4-cell gene expression data from a study of HIV-infected people in Africa and Asia.
April 01, 2021
Video
Russell Brewer, DrPH, a research associate professor at University of Chicago Medicine, discusses the value of the pharmacist in improving access and engagement in care for Black same-gender-loving men.
March 31, 2021
P.J. Moton-Poole, a senior manager at ViiV Healthcare, discusses the role pharmacists play in addressing health care disparities in BIPOC communities.
March 30, 2021
Russell Brewer, DrPH, a research associate professor at University of Chicago Medicine, discusses the lessons from both the HIV epidemic and the COVID-19 pandemic in regard to how health systems can more effectively address health care disparities in BIPOC communities.
March 29, 2021
Russell Brewer, DrPH, a research associate professor at University of Chicago Medicine, and P.J. Moton-Poole, a senior manager at ViiV Healthcare, discuss the expansion of the accelerate initiative, which funds projects that support the health and wellbeing of Black same-gender-loving men throughout the United States.
Investigators may have found a way to locate chemicals capable of suppressing HIV into its dormant state.
March 25, 2021
Although ART has helped improve the health of those with HIV, they are at a greater risk of developing complications related to chronic inflammation, such as cardiovascular disease.
March 18, 2021
TDF-based therapy is associated with renal adverse effects (AEs) and bone loss, whereas TAF-based therapy has been associated with fewer AEs.
March 16, 2021
Some HIV antibody variants, which had mutations concentrated in antibody framework regions, achieved up to 37% neutralization breadth compared to 28% neutralization in the unmodified antibody.